Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ribosome Profiling02:24

Ribosome Profiling

3.2K
Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
3.2K
Riboswitches01:56

Riboswitches

7.9K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
7.9K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

4.4K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.4K
Ribozymes02:47

Ribozymes

2.7K
2.7K
Cell Polarization by Rho Proteins01:21

Cell Polarization by Rho Proteins

3.1K
Cell polarity is the asymmetric distribution of cellular and membrane components, making one side of the cell different from the other. This polarity is essential to many processes such as embryogenesis, axon migration, glucose transport across epithelial cells, and directional cell migration. A migrating cell responds to intracellular or extracellular signals via molecular cascades that reorganize the actin cytoskeleton to establish this polarity. In these cells, the Rho family proteins Cdc42,...
3.1K
Directing Proteins to the Rough Endoplasmic Reticulum01:34

Directing Proteins to the Rough Endoplasmic Reticulum

11.9K
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
11.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Free Hemoglobin Increases Endothelial Adhesiveness to Red Blood Cells via a Toll-like Receptor 4-Dependent Mechanism.

The Journal of surgical research·2026
Same author

Optimizing post brain death vascularized composite graft quality through ex vivo restoration of S-nitrosothiol homeostasis.

Scientific reports·2025
Same author

Author response to Letter to the Editor: "Re: Elevated cell-free hemoglobin: A novel early biomarker following traumatic injury".

The journal of trauma and acute care surgery·2025
Same author

Elevated cell-free hemoglobin: A novel early biomarker following traumatic injury.

The journal of trauma and acute care surgery·2024
Same author

Renal dysfunction in adults following cardiopulmonary bypass is linked to declines in S-nitroso hemoglobin: a case series.

Annals of medicine and surgery (2012)·2024
Same author

Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): five-year outcomes of a randomised trial.

EClinicalMedicine·2024
Same journal

Editorial.

The American orthoptic journal·2017
Same journal

Editorial.

The American orthoptic journal·2017
Same journal

Editorial.

The American orthoptic journal·2017
Same journal

Congenital Cranial Dysinnervation Disorders: A Literature Review.

The American orthoptic journal·2017
Same journal

Alfred Bielschowsky, 1871-1940: Ophthalmologist, Innovative Scientist, and Influential Teacher.

The American orthoptic journal·2017
Same journal

Early Onset Sixth-Nerve Palsy with Eccentric Fixation.

The American orthoptic journal·2017
See all related articles

Related Experiment Video

Updated: Apr 22, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

16.2K

Insights in ROP.

James D Reynolds1

  • 1From the Ross Eye Institute, University at Buffalo, Buffalo, New York.

The American Orthoptic Journal
|October 15, 2014
PubMed
Summary
This summary is machine-generated.

Retinopathy of prematurity (ROP) management is improving, but new controversies in classification, incidence, screening, and treatment with anti-VEGF agents require further research for optimal infant eye care.

Keywords:
intravitreal bevacizumab (IVB)retinal schisisretinopathy of prematurity (ROP)vascular endothelial growth factor (VEGF)vitreous hemorrhage

More Related Videos

Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing RIPiT-Seq
09:26

Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing RIPiT-Seq

Published on: July 10, 2019

10.0K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

850

Related Experiment Videos

Last Updated: Apr 22, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
05:28

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

16.2K
Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing RIPiT-Seq
09:26

Identification of Footprints of RNA:Protein Complexes via RNA Immunoprecipitation in Tandem Followed by Sequencing RIPiT-Seq

Published on: July 10, 2019

10.0K
Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

850

Area of Science:

  • Ophthalmology
  • Neonatology
  • Developmental Biology

Background:

  • Retinopathy of prematurity (ROP) is a complex disease influenced by retinal metabolic demand and vascular endothelial growth factor (VEGF).
  • Understanding ROP pathophysiology is crucial for improving clinical management and outcomes in premature infants.

Discussion:

  • Current ROP classification is reliable, but disease behavior can present challenges.
  • Debates exist regarding the true incidence of Zone I and plus disease.
  • Screening guidelines lack transparency, and anti-VEGF agents like bevacizumab raise systemic safety concerns.

Key Insights:

  • Disease classification accuracy is high, yet exceptions challenge the system.
  • Incidence data for specific ROP stages remain debated.
  • Intravitreal anti-VEGF therapy, while common, necessitates careful consideration of systemic safety.

Outlook:

  • Continued research is needed to refine ROP classification and screening protocols.
  • Further investigation into the systemic safety and efficacy of anti-VEGF agents is warranted.
  • Addressing ROP co-morbidities like retinal schisis and vitreous hemorrhage is essential for improving long-term prognosis.